Web Stats Provided By Google Analytics

Friday, January 24, 2014

Can personalized tumor vaccines improve interleukin-2 treated metastatic melanoma?

New Rochelle, NY, January 22, 2014-Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 can extend survival.



via New Rochelle Newswire http://ift.tt/M31dnS

No comments:

Popular New Rochelle Roundup Posts